Sionna Therapeutics, Inc. (SION) stock
SIONNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.83−0.15 (-4.88%)
Close on Nov 20, 2026Market cap $127.73MP/E –Yield –
Sionna Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Sionna Therapeutics's free cash flow for the twelve months ending Sep 30, 2026 was -$79.61M. For fiscal 2025 it was -$66.67M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$66.67M | – |
| FY2024 | Dec 31, 2024 | -$52.81M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$18.72M | – |
| Q2 FY2026 | Jun 30, 2026 | -$22.22M | – |
| Q1 FY2026 | Mar 31, 2026 | -$21.84M | – |
| Q4 FY2025 | Dec 31, 2025 | -$16.83M | – |
| Q3 FY2025 | Sep 30, 2025 | -$15.32M | – |
| Q2 FY2025 | Jun 30, 2025 | -$18.15M | – |
| Q1 FY2025 | Mar 31, 2025 | -$16.37M | – |
| Q4 FY2024 | Dec 31, 2024 | -$11.81M | – |
| Q3 FY2024 | Sep 30, 2024 | -$17.69M | – |
| Q2 FY2024 | Jun 30, 2024 | -$10.15M | – |
| Q1 FY2024 | Mar 31, 2024 | -$13.18M | – |
See a number that looks wrong?